Review of reported mycotoxin exposure effects across stages of child development
Kadan G, Aral N (2021) · Current Molecular Pharmacology 14(5):770–781
A review summarized the developmental effects reported in the literature for mycotoxin exposure from the prenatal period through adolescence.
What they studied
A review of studies reporting mycotoxin exposure and developmental outcomes in children.
Exposure periods spanning prenatal, infant, childhood, and adolescent stages.
Outcomes including birth weight, immune measures, cognition, and school performance.
What they found
The authors reported associations with low birth weight and neural tube defects in the prenatal literature cited.
Immune and cognitive effects were reported in the infancy and childhood literature cited.
The authors reported that immature immune systems were the proposed basis for greater susceptibility in children.
What it does not establish
A narrative review; the underlying studies are largely observational and dietary-exposure based.
Little of the cited exposure literature concerns inhalation in buildings.
Associations reported do not establish causation or exposure thresholds.
This entry reports the study. It is not a statement about any building Sage Co. designs or constructs.
Source
- Kadan G, Aral N (2021). Effects of mycotoxins on child development · Current Molecular Pharmacology 14(5):770–781 · Read at the source
Last reviewed August 30, 2026.